What Researchers Did
Researchers conducted a systematic review to evaluate the effect of hyperbaric oxygen therapy (HBOT) on dysphagia in head and neck cancer patients after radiation therapy.
What They Found
Out of 1396 initial records, six studies met the eligibility criteria for qualitative analysis. The evidence regarding the benefits of hyperbaric oxygen therapy for dysphagia in head and neck cancer patients after radiation therapy was found to be inconsistent.
What This Means for Canadian Patients
Currently, there is no consistent evidence to definitively recommend hyperbaric oxygen therapy as a treatment for swallowing difficulties in Canadian head and neck cancer patients who have undergone radiation. Patients experiencing dysphagia should discuss established treatment options and symptom management strategies with their healthcare providers.
Canadian Relevance
This systematic review has no direct Canadian connection.
Study Limitations
The primary limitation is the inconsistency of evidence across the included studies, highlighting a need for more well-designed research with validated outcome measures and long-term follow-up.